Satiety-Promoting Chocolate Wafer Concept Meets EFSA Standards
The Israel-based private-label confectionery manufacturer selected ingredients that meet EFSA weight management claims or that are clinically proven: glucomannan and potato-derived ingredient Slendesta.
Carmit Candy Industries Ltd. (Israel) will introduce a chocolate wafer bar prototype packed with satiety ingredients at the upcoming Vitafoods trade show. The Israel-based private-label confectionery manufacturer selected ingredients that meet EFSA weight management claims or that are clinically proven: glucomannan and potato-derived ingredient Slendesta.
Glucomannan is a soluble fiber from konjac root; when ingested with water, it forms a gel in the stomach, leading to slower gastric emptying and an increased feeling of fullness. In 2010, the European Food Safety Authority (EFSA) granted glucomannan a weight-management health claim for a total daily intake of 3 g (1 g doses with 1-2 glasses of water). Carmit’s wafer bar contains 1 g of glucomannan.
The second ingredient, Slendesta, is a clinically studied branded ingredient from Kemin (Des Moines, IA). It is a proteinase inhibitor, which increases the release of cholecystokinin (CCK), signaling feelings of fullness. Carmit’s bar includes 300 mg of Slendesta.
CRN NY State lawsuit update: Dispatch from SupplySide East 2024
April 18th 2024CRN's Steve Mister updates Nutritional Outlook about its ongoing litigation against NY State. The organization sued the state to prevent the enforcement of law that bans sale of weight management supplements to minors.
U.S. Hemp Authority announces Adult Use Hemp Product Certification Program
April 15th 2024The U.S. Hemp Authority (USHA) has announced the launch of its Adult Use Hemp Product Certification Program in an effort to “reshape public policy around hemp, and to build confidence among retailers and consumers alike.”
Microalgae extract supports metabolic health and bone mass during diet and exercise routine
April 11th 2024The extract from Microphyt, called PhaeOptim, was shown to complement weight management strategies that include diet and exercise by support bone mass, aerobic capacity, resting heart rate, and blood lipid profiles.
